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Title:
Cathelicidin Anti-Microbial Peptide (CAMP) is toxic during neonatal influenza virus infection
Background:
Respiratory viral infections are a major public health concern for premature infants, who are at
increased risk of significant morbidity and mortality. To determine mechanisms of infant infection
susceptibility, an age-appropriate pre-clinical model of neonatal influenza virus infection in 3-day
old neonatal mice has been established. Previous work demonstrated that influenza-infected
neonatal mice treated with Lactobacillus rhamnosus GG (LGG) prior to infection had improved
survival. Several key anti-viral cytokines were upregulated, compared to sham-treated
counterparts. Surprisingly, CAMP, an important innate immune component with a broad spectrum
of antimicrobial activity, was down-regulated.
Objective:
To determine the role of CAMP in the innate immune response and subsequent pathogenesis
during neonatal influenza virus infection.
Design/Methods:
Wild-type (C57BL/6) and CAMP deficient (CAMP-/-) 3-day old neonatal and 8-week old adult
mice were infected intranasally with influenza A virus/Puerto Rico/8 (PR8) and tracked for
survival. In separate experiments, murine neonatal lungs were harvested at 1-, 3- and 6-days postinfection (DPI). Bronchoalveolar lavage fluid (BALF) and whole lungs were analyzed by flow
cytometry for cellular infiltration. Animal work was conducted according to approved IACUC
protocols.
Results:
Three-day old CAMP-/- murine neonates had improved survival compared to wild-type (75%
versus 14%, p<0.05). This is in direct opposition to adult mice, where CAMP-/- and wild-type mice
had similar weight loss, an important indicator of adult influenza-related morbidity. At 1- and 6DPI, neonatal CAMP-/- mice had increased absolute numbers and frequency of alveolar
macrophages (AM) compared to wild-type mice (p<0.05). However, in the lung interstitium, AMs
were increased in wild-type mice compared to CAMP-/- mice at 1 DPI (p<0.05). There is a delayed
production of pro-inflammatory cytokines IL-6 and IFN-gamma by the wild type mice with a
significant difference seen at 6DPI compared to 3DPI (p<0.05).
At 1DPI the CAMP-/- mice have increased viral loads compared to the wild type mice (p<0.05) but
as the disease progresses, the viral loads in the wild type mice become significantly increased by
6 DPI compared to early on in the infectious process (p<0.05).
Conclusion:

Neonatal CAMP-/-, but not adult, mice are protected during influenza virus infection. CAMP-/neonates preferentially recruit AMs to the site of infection, compared to their wild-type
counterparts with increased AMs in the interstitium. The CAMP-/- mice also seem to have a
controlled response to the influenza virus by early production of pro-inflammatory cytokines and
chemokines compared to their wild type counterparts who have a persistent pro-inflammatory state
most likely driving the increased mortality seen in this subset. This targeted response potentially
plays a role in the improved CAMP-/- survival, as AMs are critical to the control of inhaled
pathogens. Further studies using our murine model will further investigate the role of AMs as the
first-line of defense during neonatal respiratory viral infection.

